Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.1050
- TODAY'S CHANGE (%)0.0950 (3.1561%)
- Bid / Lots3.1000/ 11
- Ask / Lots3.1100/ 7
- Open / Previous Close3.1600 / 3.0100
- Day Range
- 52 Week Range
- Volume2,209,078
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 83814 | 3.1 |
| 09:33 ET | 31952 | 3.1701 |
| 09:35 ET | 25898 | 3.08 |
| 09:37 ET | 25772 | 2.99 |
| 09:39 ET | 22366 | 3.01 |
| 09:42 ET | 16225 | 3.008 |
| 09:44 ET | 15420 | 2.9991 |
| 09:46 ET | 27983 | 2.9771 |
| 09:48 ET | 23349 | 2.97 |
| 09:50 ET | 22230 | 2.9599 |
| 09:51 ET | 11386 | 2.98 |
| 09:53 ET | 7090 | 2.995 |
| 09:55 ET | 6744 | 2.9893 |
| 09:57 ET | 9478 | 2.9699 |
| 10:00 ET | 19856 | 2.9772 |
| 10:02 ET | 11736 | 3.02 |
| 10:04 ET | 2397 | 3.005 |
| 10:06 ET | 12238 | 3.025 |
| 10:08 ET | 4836 | 2.985 |
| 10:09 ET | 9754 | 3 |
| 10:11 ET | 22305 | 2.985 |
| 10:13 ET | 11834 | 2.975 |
| 10:15 ET | 21115 | 3 |
| 10:18 ET | 9874 | 3.035 |
| 10:20 ET | 29248 | 3.025 |
| 10:22 ET | 52108 | 3.005 |
| 10:24 ET | 30359 | 3.04 |
| 10:26 ET | 26093 | 3.035 |
| 10:27 ET | 23259 | 3.0292 |
| 10:29 ET | 13786 | 3.0295 |
| 10:31 ET | 16449 | 3.02 |
| 10:33 ET | 23173 | 3.025 |
| 10:36 ET | 7591 | 3.0356 |
| 10:38 ET | 6125 | 3.031 |
| 10:40 ET | 16286 | 3.065 |
| 10:42 ET | 4072 | 3.045 |
| 10:44 ET | 18354 | 3.02 |
| 10:45 ET | 4773 | 3.015 |
| 10:47 ET | 2700 | 3.025 |
| 10:49 ET | 5002 | 3.03 |
| 10:51 ET | 6051 | 3.045 |
| 10:54 ET | 23405 | 3.03 |
| 10:56 ET | 12527 | 3.0299 |
| 10:58 ET | 1919 | 3.015 |
| 11:00 ET | 3644 | 3.025 |
| 11:02 ET | 2270 | 3.015 |
| 11:03 ET | 1336 | 3.01 |
| 11:05 ET | 77095 | 2.985 |
| 11:07 ET | 7743 | 2.97 |
| 11:09 ET | 5720 | 3 |
| 11:12 ET | 23093 | 2.985 |
| 11:14 ET | 2939 | 2.98 |
| 11:16 ET | 2768 | 2.99 |
| 11:18 ET | 4765 | 3.03 |
| 11:20 ET | 2230 | 3.01 |
| 11:21 ET | 44770 | 3.02 |
| 11:23 ET | 5157 | 3.02 |
| 11:25 ET | 8666 | 3.015 |
| 11:27 ET | 3206 | 3.015 |
| 11:30 ET | 28176 | 3 |
| 11:32 ET | 8266 | 3.02 |
| 11:34 ET | 2300 | 3.03 |
| 11:36 ET | 3384 | 3.05 |
| 11:38 ET | 55953 | 3.025 |
| 11:39 ET | 22777 | 3.02 |
| 11:41 ET | 11431 | 3.025 |
| 11:43 ET | 100 | 3.02 |
| 11:45 ET | 19284 | 3.04 |
| 11:48 ET | 47304 | 3.04 |
| 11:50 ET | 2535 | 3.04 |
| 11:52 ET | 200 | 3.035 |
| 11:54 ET | 10609 | 3.055 |
| 11:56 ET | 13492 | 3.055 |
| 11:57 ET | 3643 | 3.072 |
| 11:59 ET | 3570 | 3.095 |
| 12:01 ET | 1400 | 3.095 |
| 12:03 ET | 4782 | 3.105 |
| 12:06 ET | 7192 | 3.105 |
| 12:08 ET | 3030 | 3.105 |
| 12:10 ET | 25830 | 3.07 |
| 12:12 ET | 1800 | 3.07 |
| 12:14 ET | 930 | 3.075 |
| 12:15 ET | 6003 | 3.08 |
| 12:17 ET | 1762 | 3.08 |
| 12:19 ET | 2167 | 3.09 |
| 12:21 ET | 3517 | 3.09 |
| 12:24 ET | 215892 | 3.135 |
| 12:26 ET | 26760 | 3.155 |
| 12:28 ET | 16287 | 3.115 |
| 12:30 ET | 23773 | 3.14 |
| 12:32 ET | 17803 | 3.115 |
| 12:33 ET | 1259 | 3.115 |
| 12:35 ET | 1844 | 3.13 |
| 12:37 ET | 9158 | 3.115 |
| 12:39 ET | 2867 | 3.125 |
| 12:42 ET | 700 | 3.1238 |
| 12:44 ET | 3976 | 3.11 |
| 12:46 ET | 1300 | 3.11 |
| 12:48 ET | 2117 | 3.105 |
| 12:50 ET | 1531 | 3.11 |
| 12:51 ET | 1900 | 3.115 |
| 12:53 ET | 502 | 3.105 |
| 12:55 ET | 722 | 3.1 |
| 12:57 ET | 1460 | 3.1 |
| 01:00 ET | 3054 | 3.09 |
| 01:02 ET | 2938 | 3.1 |
| 01:04 ET | 900 | 3.105 |
| 01:06 ET | 500 | 3.105 |
| 01:08 ET | 1200 | 3.105 |
| 01:09 ET | 11483 | 3.105 |
| 01:11 ET | 6705 | 3.125 |
| 01:13 ET | 3190 | 3.12 |
| 01:15 ET | 3097 | 3.11 |
| 01:18 ET | 900 | 3.105 |
| 01:20 ET | 1868 | 3.1 |
| 01:22 ET | 2100 | 3.105 |
| 01:24 ET | 7368 | 3.115 |
| 01:26 ET | 101420 | 3.115 |
| 01:27 ET | 400 | 3.11 |
| 01:29 ET | 4389 | 3.125 |
| 01:31 ET | 18435 | 3.12 |
| 01:33 ET | 24207 | 3.12 |
| 01:36 ET | 11740 | 3.129 |
| 01:38 ET | 2307 | 3.11 |
| 01:40 ET | 4767 | 3.13 |
| 01:42 ET | 13545 | 3.13 |
| 01:44 ET | 2300 | 3.13 |
| 01:45 ET | 11237 | 3.125 |
| 01:47 ET | 2729 | 3.1289 |
| 01:49 ET | 16435 | 3.119 |
| 01:51 ET | 2516 | 3.11 |
| 01:54 ET | 13642 | 3.105 |
| 01:56 ET | 10806 | 3.11 |
| 01:58 ET | 1521 | 3.12 |
| 02:00 ET | 5624 | 3.11 |
| 02:02 ET | 3278 | 3.11 |
| 02:03 ET | 2064 | 3.115 |
| 02:05 ET | 6070 | 3.105 |
| 02:07 ET | 1300 | 3.105 |
| 02:09 ET | 10107 | 3.115 |
| 02:12 ET | 6546 | 3.105 |
| 02:14 ET | 3246 | 3.105 |
| 02:16 ET | 3850 | 3.1 |
| 02:18 ET | 9329 | 3.09 |
| 02:20 ET | 4925 | 3.1097 |
| 02:21 ET | 7000 | 3.09 |
| 02:23 ET | 9169 | 3.105 |
| 02:25 ET | 1200 | 3.105 |
| 02:27 ET | 1400 | 3.1 |
| 02:30 ET | 2878 | 3.105 |
| 02:32 ET | 2344 | 3.105 |
| 02:34 ET | 2404 | 3.105 |
| 02:36 ET | 7335 | 3.105 |
| 02:38 ET | 3864 | 3.11 |
| 02:39 ET | 10556 | 3.09 |
| 02:41 ET | 3680 | 3.095 |
| 02:43 ET | 3896 | 3.105 |
| 02:45 ET | 100 | 3.105 |
Yesterday
Nov 13, 2024
DJ Autolus Therapeutics Price Target Maintained With a $10.00/Share by Needham, from 12:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
*DJ Autolus Therapeutics 3Q Loss/Shr 31c >AUTL, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow JonesAutolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow JonesDJ Autolus Therapeutics Is Maintained at Buy by Needham, from 4:41AM ET on Tuesday Nov 12, 2024 by Dow Jones
4:41AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 800.9M | -2.6x | --- |
Rapport Therapeutics Inc | 804.0M | 0.0x | --- |
Erasca Inc | 793.8M | -3.2x | --- |
CARGO Therapeutics Inc | 780.4M | -4.6x | --- |
Replimune Group Inc | 778.9M | -3.5x | --- |
Tyra Biosciences Inc | 826.9M | -9.6x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $800.9M |
|---|---|
Revenue (TTM) | $10.1M |
Shares Outstanding | 266.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.98 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 79.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,045.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
